CAREX
Price
$21.41
Change
+$0.22 (+1.04%)
Updated
Jun 22 closing price
Net Assets
54.42M
RSLBX
Price
$71.50
Change
+$0.59 (+0.83%)
Updated
Jun 22 closing price
Net Assets
91.47B
Interact to see
Advertisement

CAREX vs RSLBX

CAREX vs RSLBX Comparison Chart in %
View a ticker or compare two or three
VS
CAREX vs. RSLBX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAREX is a StrongBuy and RSLBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLBX has more cash in the bank: 91.5B vs. CAREX (54.4M). RSLBX pays higher dividends than CAREX: RSLBX (0.18) vs CAREX (0.00). CAREX was incepted earlier than RSLBX: CAREX (6 years) vs RSLBX (24 years). CAREX (2.05) is less costly to investors than RSLBX (1.74). CAREX is a more actively managed with annual turnover of: 64.00 vs. RSLBX (41.00). RSLBX has a lower initial minimum investment than CAREX: RSLBX (250) vs CAREX (2500). CAREX annual gain was more profitable for investors over the last year : 32.81 vs. RSLBX (22.00). CAREX return over 5 years is better than : 14.71 vs. RSLBX (-6.61).
CAREXRSLBXCAREX / RSLBX
Total Expense Ratio1.301.7475%
Annual Report Gross Expense Ratio2.051.74118%
Fund Existence6 years24 years-
Gain YTD18.01616.431110%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets54.4M91.5B0%
Annual Yield % from dividends0.000.18-
Returns for 1 year32.8122.00149%
Returns for 3 years60.2338.68156%
Returns for 5 years14.71-6.61-223%
Returns for 10 years194.4683.50233%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMPAX16.360.03
+0.16%
Columbia Mid Cap Index Inst
GSISX36.39N/A
N/A
Goldman Sachs International Eq ESG Svc
IJSSX16.63N/A
N/A
VY® JPMorgan Small Cap Core Equity S
EXEYX14.37N/A
N/A
Manning & Napier Equity Series S
MLACX2.88-0.02
-0.69%
NYLI Winslow Large Cap Growth Class C